BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He H, Xiang Y, Gao F, Bai L, Gao F, Fan Y, Lyu J, Ma X. Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis. Journal of Psychiatric Research 2019;118:21-30. [DOI: 10.1016/j.jpsychires.2019.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Kong W, Deng H, Wan J, Zhou Y, Zhou Y, Song B, Wang X. Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials. Front Pharmacol 2020;11:580858. [PMID: 33343351 DOI: 10.3389/fphar.2020.580858] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Szekeres G, Rozsa S, Dome P, Barsony G, Gonda X. A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder. Front Psychiatry 2021;12:689143. [PMID: 34220591 DOI: 10.3389/fpsyt.2021.689143] [Reference Citation Analysis]
3 Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry 2020;11:595584. [PMID: 33424664 DOI: 10.3389/fpsyt.2020.595584] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
4 Kim SI, Shin J, Tran Q, Park H, Kwon HH, Shin N, Hwang JA, Shin HJ, Lee J, Lee WH, Lee SY, Kim DW. Application of PLGA nanoparticles to enhance the action of duloxetine on microglia in neuropathic pain. Biomater Sci 2021. [PMID: 34378557 DOI: 10.1039/d1bm00486g] [Reference Citation Analysis]
5 Liu C, Dai J, Chen Y, Qi Z, Xin F, Zhuang Q, Zhou X, Zhou F, Luo L, Huang Y, Wang J, Zou Z, Chen H, Kendrick KM, Zhou B, Xu X, Becker B. Disorder- and emotional context-specific neurofunctional alterations during inhibitory control in generalized anxiety and major depressive disorder. Neuroimage Clin 2021;30:102661. [PMID: 33866301 DOI: 10.1016/j.nicl.2021.102661] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Zeng Y, Dong J, Huang M, Zhang JE, Zhang X, Xie M, Wefel JS. Nonpharmacological interventions for cancer-related cognitive impairment in adult cancer patients: A network meta-analysis. Int J Nurs Stud 2020;104:103514. [PMID: 32004776 DOI: 10.1016/j.ijnurstu.2019.103514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Leichsenring F, Steinert C, Rabung S, Ioannidis JPA. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses. World Psychiatry 2022;21:133-45. [PMID: 35015359 DOI: 10.1002/wps.20941] [Reference Citation Analysis]
8 Stein DJ. Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine. Adv Ther 2021;38:52-60. [PMID: 34417992 DOI: 10.1007/s12325-021-01860-1] [Reference Citation Analysis]